-

Former Olympian Gail Devers, Emily Rapp Black, Jim Geraghty Among Speakers Announced for Global Genes 11th Annual RARE Patient Advocacy Summit

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes, a leading rare disease patient advocacy organization, today announced the 2022 RARE Patient Advocacy Summit. In its 11th year, the Summit brings together rare disease patients, healthcare professionals, researchers, advocates and allies to connect, share experiences and resources, and gather insights about the latest rare disease innovations. The Summit will be held September 12-14, 2022, both in-person in San Diego, CA, and virtually.

This year’s Summit will focus on a wide range of discussions that aim to help individuals and organizations build meaningful skills, provide support and guidance for rare disease communities, advocates and families. Sessions will cover topics such as the sibling experience, fundraising best practices, preventing burnout, new data & technology and more.

“We are living in a time where connection is vitally important,” said Craig Martin, CEO of Global Genes. “For people living with any of the 10,000+ rare diseases, it’s often difficult to find support, experts, or community, and to have your voice heard. Our Summit gathers advocates, caregivers and individuals looking to connect with others from various backgrounds and sectors tied to rare disease and who can help or guide them. We provide a unique and welcoming experience where those connections happen, and people are empowered to take the next best steps forward in their journeys.”

Among the sessions in this year's Summit, key features include:

● Keynote speakers

○ Three time Olympian Gail Devers, who has been living with Thyroid Eye Disease (TED)

○ NYT best selling writer Emily Rapp Black, whose child was diagnosed at 9 months old with Tay-Sachs and passed away just before he turned 3.

● Storyteller Alley, a dedicated space within the Summit designed to help teach attendees the power of storytelling to better assist in communication about their organization, goals and mission.

● Networking opportunities throughout the Summit, including an interactive program where advocacy organization leaders can engage, learn, build off one another, and collaborate with peer organizations on a number of different areas of expertise and topics of interest.

● Leaders who have made a significant impact in advocacy, industry and medical care, as well as up-and-coming rare disease leaders will be honored with the 2022 Champions of Hope Award.

The 11th annual RARE Patient Advocacy Summit is possible thanks to sponsors including Horizon Therapeutics, Genentech, Travere Therapeutics and Pfizer, Inc. For more information and to register please visit: https://globalgenes.org/event/rare-patient-advocacy-summit/

About Global Genes

Global Genes is a leading non-profit organization dedicated to overcoming challenges facing the more than 400 million people worldwide living with rare diseases. We are a globally connected, collaborative, multi-stakeholder community that supports global innovation and equitable access to diagnosis, treatment, services, care and participation in research and advocacy. Together with our partners, we provide programs, resources, tools and insights to inform, equip and empower patients, caregivers and advocates to drive progress within and across rare diseases. If you or someone you love has a rare disease or are searching for a diagnosis, contact Global Genes at 949-248-RARE or visit our Resource Hub.

Contacts

Global Genes:
Laura Vinci
Finn Partners
402-499-8203
laura.vinci@finnpartners.com

Global Genes


Release Versions

Contacts

Global Genes:
Laura Vinci
Finn Partners
402-499-8203
laura.vinci@finnpartners.com

More News From Global Genes

In Partnership with Global Genes, Congenital Hyperinsulinism International Hosts Inaugural Family Meet-Up

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes, a leading patient advocacy organization, and Congenital Hyperinsulinism International (CHI), a foremost nonprofit dedicated to improving the lives of children and adults living with congenital hyperinsulinism (HI), today announced the inaugural CHI Family Meet-Up. The one-day event aims to provide the opportunity for those in the community and their families to connect, share their stories, and to learn about new findings from the Hyperinsulin...

In Partnership with Global Genes, Youngtimers Hosts Inaugural Leadership Summit

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes, a leading patient advocacy organization, and Youngtimers, the only US nonprofit organization dedicated to providing education, support, resources for the early onset familial Alzheimer’s disease (EOFAD) community today announced the inaugural Youngtimers Leadership Summit. The four-day event aims to gather key stakeholders to facilitate dialogue around the gaps in the field and how to prioritize the patient perspective, as well as the future o...

Two Leading Rare Disease Organizations Join Forces to Enable and Accelerate Patient-Led Engagement and Advance Research

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes and RARE-X, leaders in rare disease patient advocacy and capacity building, today announced that their respective boards of directors have signed a definitive agreement to combine the two organizations. This merger will enable the combined organization to provide the next generation of rare disease advocates the tools and resources they need to accelerate their drive for treatments. “This patient-focused, and science-driven partnership will cha...
Back to Newsroom